Hikma Pharmaceuticals PLC
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
3,086.04 |
3,117.86 |
3,269.79 |
3,474.02 |
3,728.76 |
4,026.44 |
| Przychód Δ r/r |
0.00% |
1.03% |
4.87% |
6.25% |
7.33% |
7.98% |
| Przychód (min) |
3,063.10 |
3,082.70 |
3,168.34 |
3,365.14 |
3,649.00 |
3,940.32 |
| Przychód (max) |
3,103.10 |
3,158.16 |
3,326.81 |
3,582.91 |
3,785.57 |
4,087.79 |
| EBITDA (średnia) |
795.62 |
804.59 |
843.79 |
896.50 |
962.23 |
1,039.05 |
| EBIT (średnia) |
617.40 |
624.36 |
654.78 |
695.68 |
746.69 |
806.31 |
| EBIT % |
20.01% |
20.03% |
20.03% |
20.03% |
20.03% |
20.03% |
| Zysk netto (średni) |
474.31 |
458.04 |
515.04 |
588.95 |
646.37 |
745.47 |
| Zysk netto % |
15.37% |
14.69% |
15.75% |
16.95% |
17.33% |
18.51% |
| EPS (średnia) |
2.19 |
2.16 |
2.37 |
2.64 |
2.89 |
3.34 |
| Liczba analityków (Przychody) |
8 |
10 |
10 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
6 |
8 |
8 |
4 |
3 |
2 |
| symbol |
HIK.L |
HIK.L |
HIK.L |
HIK.L |
HIK.L |
HIK.L |